
The Economic Case for AI-Driven Diagnoses of Rare Diseases
Imagine facing a health issue so elusive that it takes years—even decades—to diagnose. Meanwhile, your work performance suffers, your income dwindles, and your quality of life declines. For millions of people with rare diseases, this isn’t just a nightmare scenario; it’s their daily reality. Rare diseases, affecting fewer than 5 in 10,000 people in Europe […]
Read more →